Published in Rev Neurol (Paris) on January 31, 2008
Ketogenic diet for adults in super-refractory status epilepticus. Neurology (2014) 1.49
Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol (2011) 1.31
Adenosine, ketogenic diet and epilepsy: the emerging therapeutic relationship between metabolism and brain activity. Curr Neuropharmacol (2009) 1.04
The fat is in the fire: ketogenic diet for refractory status epilepticus. Epilepsy Curr (2011) 0.81
Effects of a ketogenic diet on hippocampal plasticity in freely moving juvenile rats. Physiol Rep (2015) 0.77
Dietary therapy for epilepsy: the advantage of rapid onset of action. Epilepsy Curr (2009) 0.75
A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature (2010) 4.52
Unusual MR findings of the brain stem in arterial hypertension. AJNR Am J Neuroradiol (2000) 3.47
STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology (2008) 2.93
Idiopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology (2005) 2.53
Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatients. Clin Pharmacol Ther (2009) 2.04
Ethiopia: between Sub-Saharan Africa and western Eurasia. Ann Hum Genet (2005) 1.98
MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations. J Med Genet (2009) 1.67
Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome. Neurology (2011) 1.65
ATPase activity of the sulfonylurea receptor: a catalytic function for the KATP channel complex. FASEB J (2000) 1.62
Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology (1998) 1.58
Terminations of pregnancy in the European Union. BJOG (2011) 1.55
Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson's disease: preliminary analysis from the French COPARK cohort. Eur J Neurol (2011) 1.53
Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP. Proc Natl Acad Sci U S A (1999) 1.49
Neuropsychological abnormalities in first degree relatives of patients with familial Parkinson's disease. J Neurol Neurosurg Psychiatry (1999) 1.47
Prominent psychiatric features and early onset in an inherited prion disease with a new insertional mutation in the prion protein gene. Brain (1999) 1.46
Efficacy and tolerance of gastrostomy feeding in Duchenne muscular dystrophy. Clin Nutr (2009) 1.45
Stimulation of the subthalamic nucleus in Parkinson's disease: cognitive and affective changes are not linked to the motor outcome. Parkinsonism Relat Disord (2006) 1.45
Cortical involvement in the sensory and motor symptoms of primary restless legs syndrome. Sleep Med (2009) 1.43
The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 1.43
Paroxysmal kinesigenic choreoathetosis as a presenting symptom of multiple sclerosis. J Neurol (2000) 1.42
Trends and determinants of reproductive health service use among young women in the USA. Hum Reprod (2009) 1.40
Dystonia after striatopallidal and thalamic stroke: clinicoradiological correlations and pathophysiological mechanisms. J Neurol Neurosurg Psychiatry (1998) 1.37
Long-term follow-up of neurosarcoidosis. Neurology (2001) 1.36
Does post-movement beta synchronization reflect an idling motor cortex? Neuroreport (2001) 1.26
Characterization of D-myo-inositol 1,4,5-trisphosphate phosphatase in rat brain. Biochem Biophys Res Commun (1986) 1.26
Expression pattern of mouse sFRP-1 and mWnt-8 gene during heart morphogenesis. Mech Dev (2000) 1.25
Outer retinal dysfunction in patients treated with vigabatrin. Neurology (1999) 1.24
A specific clinical pattern of camptocormia in Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 1.23
Quaternary ammonium compounds and occupational asthma. Int Arch Occup Environ Health (2000) 1.22
Cefepime-induced neurotoxicity: an underestimated complication of antibiotherapy in patients with acute renal failure. Intensive Care Med (2001) 1.21
Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature. Rheumatol Int (2007) 1.20
Acute myelopathies: Clinical, laboratory and outcome profiles in 79 cases. Brain (2001) 1.17
Influence of chronic bilateral stimulation of the subthalamic nucleus on cognitive function in Parkinson's disease. J Neurol (2001) 1.15
Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia? Neurology (2005) 1.15
The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity. FEBS Lett (1998) 1.12
Characterization of DCTN1 genetic variability in neurodegeneration. Neurology (2009) 1.11
Sleep disorders in aging and dementia. J Nutr Health Aging (2010) 1.10
Cloning and expression of a cDNA encoding human inositol 1,4,5-trisphosphate 3-kinase C. Biochem J (2000) 1.10
Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism? Neurology (2007) 1.10
Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up. J Neurol Neurosurg Psychiatry (2004) 1.09
Statistical tools for clinical gait analysis. Gait Posture (2004) 1.08
Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 1.08
Involvement of the N-terminus of Bax in its intracellular localization and function. FEBS Lett (2002) 1.06
Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 1.05
Study of circadian melatonin secretion pattern at different stages of Parkinson's disease. Clin Neuropharmacol (2003) 1.05
Low levels of the vascular endothelial growth factor in CSF from early ALS patients. Neurology (2004) 1.04
The expansion and selection of T cell receptor alpha beta intestinal intraepithelial T cell clones. Eur J Immunol (1996) 1.04
[Lithium-induced encephalopathy mimicking Creutzfeldt-Jakob disease]. Rev Neurol (Paris) (2006) 1.04
Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease. Fundam Clin Pharmacol (2010) 1.03
Enzymic dephosphorylation of D-myo-inositol 1,4-bisphosphate in rat brain. Biochem J (1987) 1.03
Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease. J Med Genet (2009) 1.01
Predominance of the contralateral movement-related activity in the subthalamo-cortical loop. Clin Neurophysiol (2006) 1.01
Tumor necrosis factor-alpha stimulates ICAM-1 expression in human vascular smooth muscle cells. Arterioscler Thromb (1993) 1.00
Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells. Circ Res (1994) 1.00
The integrin very late antigen-4 is expressed in human smooth muscle cell. Involvement of alpha 4 and vascular cell adhesion molecule-1 during smooth muscle cell differentiation. Circ Res (1997) 0.99
Walking patterns in Parkinson's disease with and without freezing of gait. Neuroscience (2011) 0.99
New POMT2 mutations causing congenital muscular dystrophy: identification of a founder mutation. Neurology (2007) 0.97
Vitronectin expression and interaction with receptors in smooth muscle cells from human atheromatous plaque. Arterioscler Thromb Vasc Biol (1998) 0.96
Intestinal absorption of macromolecules during viral enteritis: an experimental study on rotavirus-infected conventional and germ-free mice. Pediatr Res (1987) 0.95
Externally provoked freezing of gait in open runways in advanced Parkinson's disease results from motor and mental collapse. J Neural Transm (Vienna) (2008) 0.95
[Benign intracranial hypertension and Marchiafava-Micheli disease]. Rev Neurol (Paris) (1986) 0.95
Aminophospholipid translocase and proteins involved in transmembrane phospholipid traffic. Biophys Chem (1997) 0.95
Subthalamic nucleus stimulation induces deficits in decoding emotional facial expressions in Parkinson's disease. J Neurol Neurosurg Psychiatry (2004) 0.95
Cloning and expression in Escherichia coli of a dog thyroid cDNA encoding a novel inositol 1,4,5-trisphosphate 5-phosphatase. Biochem J (1994) 0.95
Vigilance troubles in Parkinson's disease: a subjective and objective polysomnographic study. Sleep Med (2006) 0.95
mtDNA haplogroup J: a contributing factor of optic neuritis. Eur J Hum Genet (1999) 0.94
No pathogenic mutations in the beta-synuclein gene in Parkinson's disease. Neurosci Lett (1999) 0.94
[Myasthenia gravis and pregnancy: clinical course and management of delivery and the postpartum phase]. Rev Neurol (Paris) (2006) 0.94
The dephosphorylation pathway of D-myo-inositol 1,3,4,5-tetrakisphosphate in rat brain. Biochem J (1987) 0.94
Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to (99m)Tc HmPAO SPECT data. J Neurol Neurosurg Psychiatry (2000) 0.94
Identification and cloning of a secreted protein related to the cysteine-rich domain of frizzled. Evidence for a role in endothelial cell growth control. Circ Res (1999) 0.94
Afferent-induced facilitation of primary motor cortex excitability in the region controlling hand muscles in humans. Eur J Neurosci (2009) 0.93
A transmembrane domain of the sulfonylurea receptor mediates activation of ATP-sensitive K(+) channels by K(+) channel openers. Mol Pharmacol (1999) 0.93
Impairment of the supervisory attentional system in early untreated patients with Parkinson's disease. J Neurol (1999) 0.92
[Hypothermia and multiple sclerosis. A case with 3 episodes of transient hypothermia]. Rev Neurol (Paris) (1990) 0.92
Evaluation of event-related desynchronization (ERD) during a recognition task: effect of attention. Electroencephalogr Clin Neurophysiol (1993) 0.91